GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » 12-1 Month Momentum %

Sunshine Biopharma (Sunshine Biopharma) 12-1 Month Momentum % : N/A% (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-24), Sunshine Biopharma's 12-1 Month Momentum % is N/A%.

The industry rank for Sunshine Biopharma's 12-1 Month Momentum % or its related term are showing as below:

SBFMW's 12-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -3.88
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Sunshine Biopharma's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Biopharma's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sunshine Biopharma's 12-1 Month Momentum % falls into.



Sunshine Biopharma  (NAS:SBFMW) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunshine Biopharma  (NAS:SBFMW) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sunshine Biopharma 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunshine Biopharma (Sunshine Biopharma) Business Description

Traded in Other Exchanges
Address
6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5
Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

Sunshine Biopharma (Sunshine Biopharma) Headlines

From GuruFocus

Sunshine Biopharma Initiates COVID-19 Treatment Mice Study

By ACCESSWIRE ACCESSWIRE 02-10-2021

Sunshine Biopharma: An Opportunity Knocking?

By Ishan Majumdar 05-09-2022

Sunshine Biopharma Announces Share Repurchase Program

By Stock market mentor Stock market mentor 01-19-2023